COVID-19 trials registries data warehouse

http://en.irct.ir/trial/48061

Gholamhosein Alishiri

R.bmsu@yahoo.com

2020-05-23

Completed

RCT

Randomized

Parallel

Open label

single-center

Treatment

Age: equal or more than 18 years; The patient have written consciously and freely consent to participate in the study; The patient's clinical symptoms (dry cough, shortness of breath, fever) confirm COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of symptoms.

History of allergy to this nasal spray ingredients; The patient is in another clinical trial at the same time; The patient needs to receive medical care from the intensive care unit; Pregnancy; Lactation.

2

Bagheiat-allah University of Medical Sciences

18

100

Iran

Moderate disease at enrollment

3: Moderate disease at enrollment

250

Clinical symptoms (dry cough) Clinical symptoms (respiratory distress) Clinical symptoms (fever)

Phase 3

[{"arm_notes": "", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]